ReviewCJC open2026
Non-Physician-Led Models of Care for Heart Failure Medication Optimization: A Scoping Review.
Review in CJC open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-physician-led models of care may improve utilization of heart failure (HF) medication therapy. Characterizing these models may help guide their implementation. Methods: We searched MEDLINE (National Library of Medicine), Embase (Elsevier), Cochrane Central Register of Controlled Trials (CENTRAL), and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) for studies published between January 2005 and October 2024. We included studies evaluating non-physician-led models of HFmedication management conducted at least partially in the outpatient setting. Study quality was assessed using the Oxford Centre for Evidence-Based Medicine levels of evidence, ranging from level 1 (systematic review of randomized trials) to level 5 (mechanism-based reasoning or expert opinion). Results: From 5330 records, we included 39 reports describing 31 studies with a total of 16,921 participants. All 31 studies included patients with HF with reduced ejection fraction, and 17 also included those with an ejection fraction > 40%. The levels of evidence classification in these studies were 2 (n = 2), 3 (n = 11), and 4 (n = 18).The most frequently studied professional roles were pharmacist (n = 26 studies) and nurse practitioners or clinicians (n = 9). Medication management was conducted in-person (n = 19), remotely (n = 6), and through a hybrid approach (n = 6). Median appointment frequency and duration were every 2 weeks (range: every 1-4 weeks) and 30 minutes (range: 15-60 minutes). Although non-physician-led models of care were associated with increased HF medication use compared to baseline, evidence was mixed regarding how these non-physician-led models compare to usual care in terms of improving use of guideline-directed medical therapy. Conclusions: Non-physician-led models of care are associated with improved HF medication use compared to baseline; however, substantial heterogeneity is present in implementation strategies and the impact of these improvements, compared to usual care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.